Janssen License Agreement with Nanobiotix

Sexton Riley LLP represented Janssen Pharmaceutica NV in a license agreement with Nanobiotix for a clinical stage radioenhancer for use in multiple oncology indications.

https://ir.nanobiotix.com/news-releases/news-release-details/nanobiotix-announces-license-agreement-worldwide-co-development